Cambrex To Present At UBS Global Healthcare Conference

EAST RUTHERFORD, N.J., May 11, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the UBS Global Healthcare Conference on May 18, 2015 at 9:30 a.m. EDT in New York City.

The live audio webcast and slide presentation can be accessed from the Cambrex website at www.cambrex.com in the Investors section under "Webcasts & Presentations", and a replay will be available for 90 days after the live event concludes. 

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cambrex-to-present-at-ubs-global-healthcare-conference-300080982.html

SOURCE Cambrex Corporation